These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1238 related articles for article (PubMed ID: 29800505)

  • 1. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients.
    Tan SK; Huang C; Sahoo MK; Weber J; Kurzer J; Stedman MR; Concepcion W; Gallo AE; Alonso D; Srinivas T; Storch GA; Subramanian AK; Tan JC; Pinsky BA
    J Infect Dis; 2019 Jul; 220(3):370-376. PubMed ID: 30869132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
    Schwarz A; Linnenweber-Held S; Heim A; Framke T; Haller H; Schmitt C
    Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-transplant shedding of BK virus in urine is unrelated to post-transplant viruria and viremia in kidney transplant recipients.
    Bicalho CS; Oliveira RR; Pierrotti LC; Fink MC; Urbano PR; Nali LH; Luna EJ; Romano CM; David DR; David-Neto E; Pannuti CS
    Clin Transplant; 2016 Jul; 30(7):796-801. PubMed ID: 27101526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
    Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
    Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable sources of Bk virus in renal allograft recipients.
    Urbano PRP; Nali LHDS; Oliveira RDR; Sumita LM; Fink MCDDS; Pierrotti LC; Bicalho CDS; David-Neto E; Pannuti CS; Romano CM
    J Med Virol; 2019 Jun; 91(6):1136-1141. PubMed ID: 30680753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.
    van Doesum WB; Gard L; Bemelman FJ; de Fijter JW; Homan van der Heide JJ; Niesters HG; van Son WJ; Stegeman CA; Groen H; Riezebos-Brilman A; Sanders JSF
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28258601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective monitoring of BK virus replication in renal transplant recipients.
    Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
    Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of recipient BKV shedding before transplant on BKV viruria, DNAemia, and nephropathy post-transplant: A prospective study.
    Verghese PS; Schmeling DO; Filtz EA; Matas AJ; Balfour HH
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28557148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
    Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
    J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BK virus replication in renal transplant recipients: Analysis of potential risk factors may contribute in reactivation.
    Shenagari M; Monfared A; Eghtedari H; Pourkazemi A; Hasandokht T; Khosravi M; Asharfkhani B
    J Clin Virol; 2017 Nov; 96():7-11. PubMed ID: 28915452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
    Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
    Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients.
    Imlay H; Whitaker K; Fisher CE; Limaye AP
    Transpl Infect Dis; 2018 Aug; 20(4):e12928. PubMed ID: 29809315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BK polyomavirus in the urine for follow-up of kidney transplant recipients.
    Brochot E; Descamps V; Handala L; Faucher J; Choukroun G; Helle F; Castelain S; François C; Duverlie G; Touzé A
    Clin Microbiol Infect; 2019 Jan; 25(1):112.e1-112.e5. PubMed ID: 30076973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.